ความชุกของการตรวจพบเซลล์ปากมดลูกผิดปกติระดับรุนแรงปานกลางถึงสูงในสตรีที่มาตรวจส่องกล้องปากมดลูกที่โรงพยาบาลสมุทรสาคร

pattrinee boonyapisomparn

Authors

pattrinee boonyapisomparn Samutsakhon Hospital

Keywords:

colposcopy, HSIL

Abstract

Background: Cervical cancer is common in Thailand. According to the campaign in cervical cancer screening, more patients with abnormal cervical cancer screenings underwent colposcopy. This study’s objective is to estimate the prevalence of high-grade squamous intraepithelial neoplasia (HSIL/CIN2-3) in women who underwent colposcopy.

Objective: A primary objective is to estimate the prevalence of high-grade squamous intraepithelial neoplasia in women who underwent colposcopy at Samutsakhon Hospital. A secondary objective is to identify cervical cancer screening result in women who developed high-grade squamous intraepithelial neoplasia.

Methods: This research is a retrospective cross-sectional study. Women who underwent colposcopy at Samutsakhon Hospital in Samut Sakhon, Thailand, from 1 July 2024 to 31 December 2025 were included. Medical data were obtained from the hospital database.

Results: Of the 322 patients who underwent colposcopy with cervical biopsy at Samutsakhon Hospital, 81 patients (25.2%) were found to have high-grade squamous intraepithelial neoplasia (HSIL). Among them, 52 patients (64.2%) had HPV infection, while 29 patients (35.8%) had abnormal PAP smears: the most common PAP smear result was HSIL (16 patients).

Conclusion: The prevalence of HSIL among women who underwent colposcopy at Samutsakhon Hospital was 25.2%. The study found that HPV infection was the most common abnormal cervical cancer screening result in those who were diagnosed with HSIL.

References

งานฐานข้อมูลผู้ป่วยโรคมะเร็ง. ทะเบียนมะเร็งระดับโรงพยาบาล พ.ศ. 2566: Hospital-based cancer registry 2023. กรุงเทพมหานคร: กรมการแพทย์; 2568.

WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem [internet]. 2020 [cited 2025 Nov 15]; Available from: URL: www.who.int/publications/i/item/9789240014107

Giuliano AR. The road to cervical cancer elimination. In: Ramirez AG, Trapido EJ, editors. Advancing the science of cancer in latinos: Building collaboration for action. Cham (CH): Springer. 2023;Chapter 17:199–206. doi: 10.1007/978-3-031-14436-3_17

The Lancet Oncology. Global elimination of cervical cancer is achievable-with commitment. Lancet Oncol. 2019;20(11):1467. doi: 10.1016/S1470-2045(19)30647-3.

Hariprasad R, Mittal S, Basu P. Role of colposcopy in the management of women with abnormal cytology. Cytojournal. 2022;19:40. doi: 10.25259/CMAS_03_15_2021.

Zhang B, Hong S, Zhang G, Rong F. Clinical application of the 2011 IFCPC colposcope terminology. BMC Womens Health. 2021;21(1):257. doi: 10.1186/s12905-021-01395-1.

Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP risk-based management consensus guidelines: Updates through 2023. J Low Genit Tract Dis. 2024;28(1):3–6. doi: 10.1097/LGT.0000000000000788.

Perez EGJ, Limon-Toledo LP, Carranza-Bustos LG, Gonzalez-Ojeda A, Cervantes-Guevara G, Cervantes-Perez E, et al. Prevalence of high-grade cervical intraepithelial neoplasia in Mexican women aged under 40 years: A cross-sectional study. J Turk Ger Gynecol Assoc. 2025;26(3):167–73. doi: 10.4274/jtgga.galenos.2025.2025-5-2.

Booth BB, Tranberg M, Gustafson LW, Christiansen AG, Lapirtis H, Krogh LM, et al. Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged ≥69 referred to colposcopy due to an HPV-positive screening test. BMC Cancer. 2023;23(1):405. doi: 10.1186/s12885-023-10888-1.

Javanbakht Z, Kamravamanesh M, Rasulehvandi R, Heidary A, Haydari M, Kazeminia M. Global prevalence of cervical dysplasia: A systematic review and meta-analysis. IJGO. 2023;21:62. doi: 10.1007/s40944-023-00741-5

Liu Q, Chen L, Yu M, Zhou X, Zhang X, Zheng W, et al. Prevalence of cervical precancers or cancers in women with ASC-H/HSIL cytology according to Aptima HPV (AHPV) assay-detected HPV genotypes and age. J Cancer. 2024;15(1):140–8. doi: 10.7150/jca.89715.

Buadi LO, Odame R, Samba A, Kareem M, Boateng AA, Diogo CA, et al. Integration and acceptability of cervical cancer screening as part of postnatal care among women attending postnatal clinics in the Accra Metropolis, Greater Accra Region, Ghana. PLOS Glob Public Health. 2024;4(12):e0004070. doi: 10.1371/journal.pgph.0004070

Kanjanawilai N, Wisarnsirirak P, Chanthasenanont A, Pattaraarchachai J, Suwannarurk K. Knowledge attitude and practice of postpartum parturients towards cervical cancer and cervical cancer screening; Is lack of knowledge the misleading scapegoat? Asian Pac J Cancer Prev. 2022;23(6):2145–50. doi: 10.31557/APJCP.2022.23.6.2145.

Cesar JA, Souto AM, Lelis CF, Pinheiro LP, Dutra RP, Terlan RJ. Pap smears in the extreme South of Brazil: Low coverage and exposure of the most vulnerable pregnant women. Rev Bras Epidemiol. 2023;26:e230032. doi: 10.1590/1980-549720230032.

Kumari S. Screening for cervical cancer in pregnancy. Oncol Rev. 2023;17:11429. doi: 10.3389/or.2023.11429.